Latest Insider Transactions at Surrozen, Inc. (SRZN)
This section provides a real-time view of insider transactions for Surrozen, Inc. (SRZN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Surrozen, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Surrozen, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 06
2026
|
Tim Kutzkey |
BUY
Open market or private purchase
|
Indirect |
15,100
+0.8%
|
$286,900
$19.89 P/Share
|
|
Jan 06
2026
|
Column Group Iii Gp, LP |
BUY
Open market or private purchase
|
Indirect |
15,100
+0.8%
|
$286,900
$19.89 P/Share
|
|
Jan 05
2026
|
Yang Li Exec. Vice President, Research |
SELL
Open market or private sale
|
Direct |
1,118
-6.5%
|
$21,242
$19.87 P/Share
|
|
Jan 05
2026
|
Charles O Williams Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,566
-10.76%
|
$29,754
$19.87 P/Share
|
|
Jan 02
2026
|
Yang Li Exec. Vice President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+12.68%
|
-
|
|
Jan 02
2026
|
Charles O Williams Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+19.39%
|
-
|
|
Dec 15
2025
|
Craig C Parker Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,553
+15.33%
|
$12,424
$8.11 P/Share
|
|
Dec 15
2025
|
Charles O Williams Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,666
+13.1%
|
$13,328
$8.11 P/Share
|
|
Dec 15
2025
|
Yang Li Exec. Vice President, Research |
BUY
Grant, award, or other acquisition
|
Direct |
1,666
+10.17%
|
$13,328
$8.11 P/Share
|
|
Dec 05
2025
|
Tim Kutzkey |
BUY
Open market or private purchase
|
Indirect |
30,884
+1.64%
|
$586,796
$19.54 P/Share
|
|
Dec 05
2025
|
Column Group Iii Gp, LP |
BUY
Open market or private purchase
|
Indirect |
30,884
+1.64%
|
$586,796
$19.54 P/Share
|
|
Dec 04
2025
|
Tim Kutzkey |
BUY
Open market or private purchase
|
Indirect |
5,266
+0.29%
|
$89,522
$17.35 P/Share
|
|
Dec 04
2025
|
Column Group Iii Gp, LP |
BUY
Open market or private purchase
|
Indirect |
5,266
+0.29%
|
$89,522
$17.35 P/Share
|
|
Nov 13
2025
|
Tim Kutzkey |
BUY
Open market or private purchase
|
Indirect |
315,457
+14.81%
|
$3,785,484
$12.65 P/Share
|
|
Nov 13
2025
|
Column Group Iii Gp, LP |
BUY
Open market or private purchase
|
Indirect |
315,457
+14.81%
|
$3,785,484
$12.65 P/Share
|
|
Jun 13
2025
|
Yang Li Exec. Vice President, Research |
BUY
Grant, award, or other acquisition
|
Direct |
400
+2.98%
|
$3,200
$8.06 P/Share
|
|
Jun 13
2025
|
Craig C Parker Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
400
+5.39%
|
$3,200
$8.06 P/Share
|
|
Jun 13
2025
|
Charles O Williams Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
400
+4.09%
|
$3,200
$8.06 P/Share
|
|
Mar 26
2025
|
Column Group Iii Gp, LP |
BUY
Open market or private purchase
|
Indirect |
1,034,482
+37.67%
|
$11,379,302
$11.6 P/Share
|
|
Jan 03
2025
|
Yang Li Exec. Vice President, Research |
SELL
Open market or private sale
|
Direct |
843
-5.94%
|
$14,331
$17.37 P/Share
|
|
Jan 03
2025
|
Charles O Williams Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,181
-11.62%
|
$20,077
$17.37 P/Share
|
|
Jan 02
2025
|
Yang Li Exec. Vice President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+14.98%
|
-
|
|
Jan 02
2025
|
Charles O Williams Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+25.62%
|
-
|
|
Jun 14
2024
|
Yang Li Exec. Vice President, Research |
BUY
Grant, award, or other acquisition
|
Direct |
400
+3.54%
|
$2,000
$5.67 P/Share
|
|
Jun 14
2024
|
Charles O Williams Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
400
+6.39%
|
$2,000
$5.67 P/Share
|
|
Jun 14
2024
|
Craig C Parker Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
400
+6.43%
|
$2,000
$5.67 P/Share
|
|
Apr 04
2024
|
Charles O Williams Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
1,474
+50.0%
|
-
|
|
Apr 04
2024
|
Craig C Parker Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,474
+50.0%
|
-
|
|
Apr 04
2024
|
Column Group Iii Gp, LP |
BUY
Open market or private purchase
|
Indirect |
193,548
+23.57%
|
$2,903,220
$15.5 P/Share
|
|
Apr 04
2024
|
Tim Kutzkey |
BUY
Open market or private purchase
|
Indirect |
193,548
+23.57%
|
$2,903,220
$15.5 P/Share
|
|
Dec 15
2023
|
Yang Li Exec. Vice President, Research |
BUY
Grant, award, or other acquisition
|
Direct |
2,085
+50.0%
|
$10,425
$5.67 P/Share
|
|
Dec 15
2023
|
Charles O Williams Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,085
+50.0%
|
$10,425
$5.67 P/Share
|
|
Dec 15
2023
|
Craig C Parker Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,046
+50.0%
|
$10,230
$5.67 P/Share
|
|
Jun 15
2023
|
Charles O Williams Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+41.96%
|
$0
$0.38 P/Share
|
|
Jun 15
2023
|
Wen Chen Yeh Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,638
+39.32%
|
$0
$0.38 P/Share
|
|
Jun 15
2023
|
Craig C Parker Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+41.96%
|
$0
$0.38 P/Share
|
|
Dec 15
2022
|
Craig C Parker Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,578
+50.0%
|
$0
$0.41 P/Share
|
|
Dec 15
2022
|
Wen Chen Yeh Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,578
+4.01%
|
$0
$0.41 P/Share
|
|
Dec 15
2022
|
Charles O Williams Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,578
+50.0%
|
$0
$0.41 P/Share
|
|
Dec 15
2022
|
Geertrui Vanhove Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,578
+22.81%
|
$0
$0.41 P/Share
|
|
Dec 14
2022
|
Mitchell J Md Blutt > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,382,499
-100.0%
|
-
|
|
Aug 11
2021
|
Kevin Harold Livingston |
BUY
Grant, award, or other acquisition
|
Indirect |
1,885,000
+46.75%
|
-
|
|
Aug 11
2021
|
Kevin Harold Livingston |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,451,000
-100.0%
|
-
|
|
Aug 11
2021
|
Kevin Harold Livingston |
SELL
Other acquisition or disposition
|
Indirect |
759,000
-34.34%
|
-
|
|
Aug 11
2021
|
Kevin Harold Livingston |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
434,000
-100.0%
|
-
|
|
Aug 11
2021
|
Benny Soffer |
BUY
Grant, award, or other acquisition
|
Indirect |
1,885,000
+46.75%
|
-
|
|
Aug 11
2021
|
Benny Soffer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,451,000
-100.0%
|
-
|
|
Aug 11
2021
|
Benny Soffer |
SELL
Other acquisition or disposition
|
Indirect |
759,000
-34.34%
|
-
|
|
Aug 11
2021
|
Benny Soffer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
434,000
-100.0%
|
-
|
|
Aug 11
2021
|
Christopher Haqq |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+50.0%
|
-
|